HIV after 25 years: How to induce a vaccine?

Journal of Internal Medicine

Volumn 263, Issue 3, 2008, Pages 215-217

  Andersson, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADAPTIVE IMMUNITY; CLINICAL TRIAL; CULTURAL ANTHROPOLOGY; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNITY; INFECTION PREVENTION; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; SEXUALITY; VACCINATION; VIRUS REPLICATION;

AIDS VACCINES; ANTIVIRAL AGENTS; HIV INFECTIONS; HIV-1; HUMANS;

EID: 38849101699     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01919.x     Document Type: Editorial

References (7)

1. Global HIV Prevalence has Levelled Off; AIDS is Among the Leading Causes of Death Globally and Remains the Primary Cause of Death in Africa. UNAIDS press release, Geneva, November 20, 2007. http://data.unaids.org.
2. Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006 368 : 489 504.
3. Kallings LO. The first postmodern pandemic: 25 years of HIV/AIDS. J Intern Med 2008 263 : 218 43.
4. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007 27 : 406 16.
5. Cohen J. AIDS research. Did Merck's failed HIV vaccine cause harm? Science 2007 318 : 1048 9.
6. Ledford H. HIV vaccine may raise risk. Nature 2007 450 : 325.
7. Hladik F, Sakchalathorn P, Ballweber L et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007 26 : 257 70.